Decoherence on a two-dimensional quantum walk using four- and two-state particle

We study the decoherence effects originating from state flipping and depolarization for two-dimensional discrete-time quantum walks using four-state and two-state particles. By quantifying the quantum correlations between the particle and position degree of freedom and between the two spatial ($x-y$) degrees of freedom using measurement induced disturbance (MID), we show that the two schemes using a two-state particle are more robust against decoherence than the Grover walk, which uses a four-state particle. We also show that the symmetries which hold for two-state quantum walks breakdown for the Grover walk, adding to the various other advantages of using two-state particles over four-state particles.Comment: 12 pages, 16 figures, In Press, J. Phys. A: Math. Theor. (2013

Asymptotic entanglement in a two-dimensional quantum walk

The evolution operator of a discrete-time quantum walk involves a conditional shift in position space which entangles the coin and position degrees of freedom of the walker. After several steps, the coin-position entanglement (CPE) converges to a well defined value which depends on the initial state. In this work we provide an analytical method which allows for the exact calculation of the asymptotic reduced density operator and the corresponding CPE for a discrete-time quantum walk on a two-dimensional lattice. We use the von Neumann entropy of the reduced density operator as an entanglement measure. The method is applied to the case of a Hadamard walk for which the dependence of the resulting CPE on initial conditions is obtained. Initial states leading to maximum or minimum CPE are identified and the relation between the coin or position entanglement present in the initial state of the walker and the final level of CPE is discussed. The CPE obtained from separable initial states satisfies an additivity property in terms of CPE of the corresponding one-dimensional cases. Non-local initial conditions are also considered and we find that the extreme case of an initial uniform position distribution leads to the largest CPE variation.Comment: Major revision. Improved structure. Theoretical results are now separated from specific examples. Most figures have been replaced by new versions. The paper is now significantly reduced in size: 11 pages, 7 figure

Quantum walks: a comprehensive review

Quantum walks, the quantum mechanical counterpart of classical random walks, is an advanced tool for building quantum algorithms that has been recently shown to constitute a universal model of quantum computation. Quantum walks is now a solid field of research of quantum computation full of exciting open problems for physicists, computer scientists, mathematicians and engineers. In this paper we review theoretical advances on the foundations of both discrete- and continuous-time quantum walks, together with the role that randomness plays in quantum walks, the connections between the mathematical models of coined discrete quantum walks and continuous quantum walks, the quantumness of quantum walks, a summary of papers published on discrete quantum walks and entanglement as well as a succinct review of experimental proposals and realizations of discrete-time quantum walks. Furthermore, we have reviewed several algorithms based on both discrete- and continuous-time quantum walks as well as a most important result: the computational universality of both continuous- and discrete- time quantum walks.Comment: Paper accepted for publication in Quantum Information Processing Journa

Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Abstract: Background: The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. Methods: This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting. Findings: Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had ‘COVID-altered’ management. ‘Bridging’ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2–9%) using ‘NHS Predict’. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey. Conclusions: The majority of ‘COVID-altered’ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown